Abstract
Quantifying the heterogeneity is an important issue in meta-analysis, and among the existing measures, the I2 statistic is most commonly used. In this article, we first illustrate with a simple example that the statistic I2 is heavily dependent on the study sample sizes, mainly because it is used to quantify the heterogeneity between the observed effect sizes. To reduce the influence of sample sizes, we introduce an alternative measure that aims to directly measure the heterogeneity between the study populations involved in the meta-analysis. We further propose a new estimator, namely the I2A statistic, to estimate the newly defined measure of heterogeneity. For practical implementation, the exact formulas of the I2A statistic are also derived under two common scenarios with the effect size as the mean difference (MD) or the standardized mean difference (SMD). Simulations and real data analyses demonstrate that the I2A statistic provides an asymptotically unbiased estimator for the absolute heterogeneity between the study populations, and it is also independent of the study sample sizes as expected. To conclude, our newly defined I2A statistic can be used as a supplemental measure of heterogeneity to monitor the situations where the study effect sizes are indeed similar with little biological difference. In such scenario, the fixed-effect model can be appropriate; nevertheless, when the sample sizes are sufficiently large, the I2 statistic may still increase to 1 and subsequently suggest the random-effects model for meta-analysis.
Original language | English |
---|---|
Article number | e70089 |
Number of pages | 18 |
Journal | Statistics in Medicine |
Volume | 44 |
Issue number | 10-12 |
DOIs | |
Publication status | Published - May 2025 |
User-Defined Keywords
- ANOVA
- heterogeneity
- intraclass correlation coefficient
- meta‐analysis
- the 𝐼2 A statistic
- the 𝐼2 statistic
- the IA2 statistic
- meta-analysis
- the I2 statistic